SBI Mutual Fund has reported a reduction in its shareholding in Neogen Chemicals Limited, decreasing its stake by 2%. This change was disclosed on August 19, 2026, following the sale of 2,11,931 shares, representing approximately 0.7740% of the company’s paid-up capital. The fund’s final holding stands at 16,50,555 shares, accounting for 6.0280% of the total equity.
SBI Mutual Fund Adjusts Neogen Chemicals Holding
SBI Mutual Fund, through its various schemes, has made a notable adjustment to its investment in Neogen Chemicals Limited. The fund disclosed on August 19, 2026, that it has reduced its shareholding in the company by 2%. This action follows a previous disclosure made on November 7, 2026, where the reported holding was 8.5930%.
Share Sale Details
Specifically, SBI Mutual Fund divested 2,11,931 shares, which constitutes approximately 0.7740% of Neogen Chemicals’ paid-up share capital. The transaction was executed as a Market Sale, with the shares being sold on August 18, 2026. This strategic sale brings the fund’s total holding in Neogen Chemicals to 16,50,555 shares, representing 6.0280% of the company’s paid-up share capital as of the close of business hours on the same day.
Disclosure Compliance
The disclosure has been made in accordance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The total equity share capital of Neogen Chemicals Limited as of the reporting date is valued at Rs. 27,38,16,740, comprising 2,73,81,674 equity shares with a face value of Rs. 10/- each.
Source: BSE
